Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders

@article{Abbas2008PimavanserinTA,
  title={Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders},
  author={A. Abbas and B. Roth},
  journal={Expert Opinion on Pharmacotherapy},
  year={2008},
  volume={9},
  pages={3251 - 3259}
}
Background: Pimavanserin tartrate is the first 5-HT2A inverse agonist to enter clinical trials as a treatment for L-dopa-induced psychosis in Parkinson's disease and for augmentation of low-dose risperidone treatment in schizophrenia. Pimavanserin is also being evaluated as a possible anti-insomnia drug. Objective: To discuss the potential of pimavanserin to fill multiple therapeutic needs. Methods: The problems with currently approved antipsychotics and sleep agents are explored to highlight… Expand
33 Citations
Pimavanserin: An Inverse Agonist Antipsychotic Drug.
  • R. Howland
  • Medicine
  • Journal of psychosocial nursing and mental health services
  • 2016
  • 11
Novel Treatments of Psychosis
  • PDF
Role of 5-HT2A receptor antagonists in the treatment of insomnia
  • 33
  • PDF
Atypical antipsychotics and inverse agonism at 5-HT2 receptors.
  • 24
Targeting the 5-HT system: Potential side effects
  • D. Hoyer
  • Biology, Medicine
  • Neuropharmacology
  • 2020
  • 3
...
1
2
3
4
...

References

SHOWING 1-10 OF 49 REFERENCES
A Comparative Review of New Antipsychotics
  • O. Blin
  • Medicine, Psychology
  • Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 1999
  • 91
H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs
  • 527
  • PDF
Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders
  • 241
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.
  • 290
  • PDF
Atypical antipsychotics in the EPS-vulnerable patient
  • 32
  • Highly Influential
PET analysis of the 5-HT2A receptor inverse agonist ACP-103 in human brain.
  • 27
  • PDF
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
  • 4,816
  • PDF
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
  • 986
  • PDF
...
1
2
3
4
5
...